This is unpublished
Mechanisms of Arrhythmia after Cardiac Stem Cell Therapy
June 21, 2024
Andrew Wescott, MD, PhD
Pinned
GRAND ROUND OBJECTIVES
- Discuss the state of clinical trials for cardiac regeneration via stem cell therapies.
- Review the preclinical breakthroughs from UW to support cardiac stem cell therapies.
- Understand the molecular signals driving arrhythmia after cardiac stem cell therapy.
ACCREDITATION FOR CARDIOVASCULAR GRAND ROUNDS
The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Washington School of Medicine designates this live activity for a maximum of 36.0 AMA PRA Category 1 Credits.
Physicians should claim only the credit commensurate with the extent of their participation in the activity. (Each session is 1.0 credit)
To request disability accommodation, contact the Office of the Disability Services Office at least ten days in advance of the event at 206-543-6450 (voice), 206-543-6452 (TTY), 206-685-7264 (FAX), dso@u.washington.edu.